Small Molecules
5 April 2017
Kura Oncology Presents Preclinical Data Demonstrating Significant Anti-Tumor Activity of KO-947 and KO-5395 April 2017
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia4 April 2017
Intensity Therapeutics Reports That INT230-6 Induces Protective T-Cell Immunity in Preclinical Models4 April 2017
TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 20173 April 2017
eFFECTOR Therapeutics Presents Positive Preclinical Data on Lead Product Candidate at AACR 20173 April 2017
Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports